SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
17.55
-0.32 (-1.79%)
Jan 13, 2026, 12:47 PM EST - Market open
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $761.52 million as of January 13, 2026. Its market cap has increased by 36.84% in one year.
Market Cap
761.52M
Enterprise Value
666.49M
1-Year Change
36.84%
Ranking
Category
Stock Price
$17.55
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $218.80M to $761.52M, an increase of 248.04%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 775.40M | -9.38% |
| Dec 31, 2025 | 855.68M | 45.53% |
| Dec 31, 2024 | 587.97M | -30.84% |
| Dec 29, 2023 | 850.12M | 81.20% |
| Dec 30, 2022 | 469.15M | -36.93% |
| Dec 31, 2021 | 743.81M | -23.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |